Variable | Univariate analysis | Â |
---|---|---|
 | HR (95% CI) | p-value |
Gender | Â | Â |
Male | 1 (Ref.) | Â |
Female | 1.246 (0.423–3.671) | 0.690 |
Age | Â | Â |
 ≤ 65y | 1 (Ref.) |  |
 > 65y | 0.787 (0.269–2.309) | 0.663 |
AA exposure | Â | Â |
No | 1 (Ref.) | Â |
Yes | 1.296 (0.483–3.477) | 0.606 |
Tumor staging | Â | Â |
 < T2 | 1 (Ref.) |  |
 ≥ T2 | 1.299 (0.574–2.939) | 0.531 |
Lymph node staging | Â | Â |
N0 | 1 (Ref.) | Â |
N +  | 0.047 (0.001–50,788.947) | 0.665 |
Tumor grade | Â | Â |
G1/G2 | 1 (Ref.) | Â |
G3 | 1.092 (0.474–2.519) | 0.836 |
Multifocality | Â | Â |
No | 1 (Ref.) | Â |
Yes | 1.138 (0.509–2.543) | 0.753 |
Tumor location | Â | Â |
Renal pelvis only | 1 (Ref.) | Â |
Ureter only | 1.447 (0.523–4.004) | 0.477 |
Pelvis and ureter | 0.965 (0.372–2.506) | 0.942 |